A phase 3, Prospective, Multicenter, Umcontrolled, Open-label Clinical Study to Determine the Efficiacy, Safety and Tolerability of Recombinant Von Willebrand Factor (rVWF) with or without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficiacy, Safety and Tolerability of rVWF in Elective and Emergency Surgeries and the Pharmacokinetics (PK) of rVWF in Children Diagnosed with Severe von Willebrand Disease | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

A phase 3, Prospective, Multicenter, Umcontrolled, Open-label Clinical Study to Determine the Efficiacy, Safety and Tolerability of Recombinant Von Willebrand Factor (rVWF) with or without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficiacy, Safety and Tolerability of rVWF in Elective and Emergency Surgeries and the Pharmacokinetics (PK) of rVWF in Children Diagnosed with Severe von Willebrand Disease

Zülfikar O. B. (Yürütücü), Koç Şenol S. B.

Diğer Uluslararası Fon Programları, 2017 - 2025

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Kasım 2017
Bitiş Tarihi: Aralık 2025